Recently, modification of the gut flora by supplementation with prebiotics has been considered to be a potential therapeutic strategy to reduce uremic toxins of intestinal origin and inflammation
Waring WS, Convery A, Mishra V, Shenkin A, Webb DJ, Maxwell SR
GLP-1 receptor agonists appear to reduce inflammation, decrease oxidative stress, and improve mitochondrial function in brain cells
7 GLP1-RAs have become increasingly more utilized medications for the treatment of diabetes mellitus and weight loss, with recent studies demonstrating possible anti-inflammatory and immunomodulatory effects as well
For Ozempic, which is FDA-approved for type 2 diabetes, the dosing schedule starts at 0.25 mg and escalates, with options to increase to 0.5 mg at week five, then 1.0 mg, and potentially up to 2.0 mg